(Q39883089)

English

Combination of Zizyphus jujuba and green tea extracts exerts excellent cytotoxic activity in HepG2 cells via reducing the expression of APRIL.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Combination of Zizyphus jujuba and green tea extracts exerts excellent cytotoxic activity in HepG2 cells via reducing the expression of APRIL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

author name string

Xuedan Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Akiko Kojima-Yuasa

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Shenghui Xu

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

David Opare Kennedy

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tadayoshi Hasuma

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Isao Matsui-Yuasa

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

The American Journal of Chinese Medicine

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

169-179

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hepatocellular carcinoma: molecular biology and therapy

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Inhibition of cyclin-dependent kinases by p21

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Gene therapy of liver cancer

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Green tea extract enhances the selective cytotoxic activity of Zizyphus jujuba extracts in HepG2 cells

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Mechanism of the anti-cancer activity of Zizyphus jujuba in HepG2 cells

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Future perspectives for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Viral hepatitis and liver cancer: the case of hepatitis C.

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Natural products as sources of new drugs over the period 1981-2002.

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Tumor-suppressor p53 and the cell cycle

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

An evaluation of three in vitro cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

The therapeutic potential of flavonoids

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

APRIL and BAFF connect autoimmunity and cancer

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X09006758

21 January 2018

Chemical constituents of cape aloe and their synergistic growth-inhibiting effect on Ehrlich ascites tumor cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB.60659

Identifiers

10.1142/S0192415X09006758

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39883089&oldid=2129836875"